Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tony Mire-Sluis"'
Autor:
Yasser Nashed-Samuel, Kiyoshi Fujimori, Linda O. Narhi, Joey Pollastrini, Gianni Torraca, Erwin Freund, Monica Pallitto, Cynthia Li, Janice M. Davis, Lisa Donahue, Tony Mire-Sluis, Aylin Vance, Zai-Qing Wen, David Mallard, Grace C. Chu, Wei Liu, Yijia Jiang
Publikováno v:
Journal of pharmaceutical sciences. 98(12)
Tungsten has been associated with protein aggregation in prefilled syringes (PFSs). This study probed the relationship between PFSs, tungsten, visible particles, and protein aggregates. Experiments were carried out spiking solutions of two different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fea862122e24172da117334f0a700a4
https://pubmed.ncbi.nlm.nih.gov/19645002
https://pubmed.ncbi.nlm.nih.gov/19645002
Autor:
Bowsher, Ronald R.
Publikováno v:
Contract Pharma; Oct2010, Vol. 12 Issue 8, p76-82, 4p, 1 Color Photograph, 3 Diagrams, 1 Chart
Autor:
Rathore, Anurag S., Mhatre, Rohin
Publikováno v:
Quality by Design for Biopharmaceuticals; 2009, p85-109, 25p
Publikováno v:
Immunogenicity of Biopharmaceuticals; 2008, p239-258, 20p
Publikováno v:
BioPharm International. Sep2008, Vol. 21 Issue 9, p14-14. 1/2p.
Autor:
Masood N. Khan, John W. A. Findlay
A consolidated and comprehensive reference on ligand-binding assays Ligand-binding assays (LBAs) stand as the cornerstone of support for definition of the pharmaco-kinetics and toxicokinetics of macromolecules, an area of burgeoning interest in the p
Autor:
Anurag S. Rathore, Rohin Mhatre
The concepts, applications, and practical issues of Quality by Design Quality by Design (QbD) is a new framework currently being implemented by the FDA, as well as EU and Japanese regulatory agencies, to ensure better understanding of the process so